GENEVA, Sept. 15 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, Gongshu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/080212) for "ANTI-FGFR2B ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF, AND USE THEREOF" on Mar 03, 2025. With publication no. WO/2025/185559, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed ...